-
1 Comment
Feedback plc is currently in a long term downtrend where the price is trading 20.6% below its 200 day moving average.
From a valuation standpoint, the stock is 93.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 28.3.
Feedback plc's total revenue sank by 0.0% to $134K since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-302K since the same quarter in the previous year.
Finally, its free cash flow fell by 119.1% to $-607K since the same quarter in the previous year.
Based on the above factors, Feedback plc gets an overall score of 1/5.
| ISIN | GB0003340550 |
|---|---|
| Exchange | LSE |
| CurrencyCode | GBP |
| Sector | Healthcare |
| Industry | Health Information Services |
| Beta | -0.03 |
|---|---|
| Target Price | 60 |
| Market Cap | 6M |
| PE Ratio | None |
| Dividend Yield | None |
Feedback plc provides software and systems to those working in the field of medical imaging. Its products include Bleepa, an image-based communication platform for frontline clinicians; CareLocker, a patient-centric cloud architecture; and Feedback Connect that enables imaging-led point-of-care decision making in remote areas. The company was incorporated in 1958 and is headquartered in London, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FDBK.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
